When Rick Siemens from Lethbridge, graduated from the University of Alberta, he quickly realized that many of his patients with diabetes were struggling with their condition.
Pfizer and French biotech Valneva are aiming to avoid previous pitfalls in developing a new vaccine to protect both adults and kids as young as 5 from the most common Lyme strains on two continents.